KIT as a master regulator of the mast cell lineage is a research paper published in Journal of Allergy and Clinical Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 118 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
United States-Israel Binational Science Foundation
Grant: 2017182
Austrian Science Fund
Grant: F4704-B20
Austrian Science Fund
Grant: P32470-B
National Institutes of Health
Grant: R01 AI132494
National Institutes of Health
Grant: R01 AI165373
National Institutes of Health
Grant: R21 AI163438
National Institutes of Health
Grant: U19 AI104209
FWCI
7.68
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors
Additional file 1 of Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors